| 000 | 00895nam a2200241 a 4500 | ||
|---|---|---|---|
| 008 | 110801s2011^^^^xxua^^^^^^^^^^001^0^eng^^ | ||
| 020 | _a9780471771517 (encuadernado) | ||
| 020 | _a0471771511 (encuadernado) | ||
| 035 | _aMX001001268099 | ||
| 040 |
_aDNLM/DLC _bspa _cDLC _dYDX _dNLM _dYDXCP _dCDX _dBWX _dDLC _dUNAMX |
||
| 050 | 0 |
_aQP623 _bR5347 |
|
| 082 | 0 | 0 |
_a572.8/8 _222 |
| 245 | 0 | 0 |
_aRNA interference : _bapplication to drug discovery and challenges to pharmaceutical development / _cedited by Paul H. Johnson |
| 264 | 1 |
_aHoboken, New Jersey : _bWiley, _cc2011 |
|
| 300 |
_axiv, 310 páginas : _bilustraciones |
||
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 650 | 0 | _aÁcido ribonucleico | |
| 650 | 0 | _aARN de pequeña interferencia | |
| 650 | 0 | _aDesarrollo de medicamentos | |
| 700 | 1 |
_aJohnson, Paul H., _d1943- _eeditor |
|
| 999 |
_c3023 _d3023 |
||